Back to top
more

Cerner Corporation (CERN)

(Delayed Data from NSDQ)

$68.47 USD

68.47
2,167,881

+0.46 (0.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $68.46 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Inogen (INGN) Announces Preliminary Q4 Results, Slashes View

by Zacks Equity Research

Inogen (INGN) expects direct-to-consumer sales to be its fastest-growing channel in 2020.

Trina Mukherjee headshot

5 Promising Growth Stocks in MedTech to Invest in 2020

by Trina Mukherjee

We have zeroed in on five impressive growth stocks in MedTech on the back of the industry's lucrative prospects.

ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View

by Zacks Equity Research

ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.

Here's Why You Should Add Cerner (CERN) to Your Portfolio

by Zacks Equity Research

Cerner (CERN) expects revenues between $1.41 billion and $1.46 billion in the fourth quarter.

Here's Why You Should Hold on to AngioDynamics Stock Now

by Zacks Equity Research

AngioDynamics (ANGO) retains fiscal 2020 view; VA revenues soft in fiscal Q2.

Walgreens Boots (WBA) Q1 Earnings Lag Estimates, Margins Fall

by Zacks Equity Research

Sluggishness in Walgreens Boots' (WBA) Retail Pharmacy International segment and margin contractions put pressure on the bottom line during Q1.

AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates

by Zacks Equity Research

AngioDynamics (ANGO) gains from core Oncology business in the fiscal second quarter, reiterates guidance.

Sreyoshi Mukherjee headshot

Bright Near-Term Outlook for Medical Info Systems Industry

by Sreyoshi Mukherjee

As the healthcare industry experiences rapid and unprecedented technological changes, let's take a look at a few promising medical info systems stocks.

MDRX or CERN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MDRX vs. CERN: Which Stock Is the Better Value Option?

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) is gaining traction from prudent strategic deals and big data based EHR system. However, weak margins remain a woe.

Sreyoshi Mukherjee headshot

SaMD Drives All Facets of US Healthcare: 3 Stocks to Watch

by Sreyoshi Mukherjee

As IoT slowly takes over the healthcare fraternity, let's take a look at three stocks which might prove to be profitable investment options over the long run.

MDRX or CERN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MDRX vs. CERN: Which Stock Is the Better Value Option?

Sreyoshi Mukherjee headshot

3 Healthcare Stocks to Counter Tech Encroachment

by Sreyoshi Mukherjee

Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.

Trina Mukherjee headshot

Digital Health Gaining Momentum: 3 MedTech Stocks in Focus

by Trina Mukherjee

Digital health is committed to changing the face of healthcare as evident from its innovative solutions for the betterment of patients' lives.

San Gorgonio Hospital Picks Allscripts Sunrise Community Care

by Zacks Equity Research

Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.

Cerner (CERN) Earnings Beat Estimates in Q3, Improve Y/Y

by Zacks Equity Research

Cerner (CERN) Q3 results benefit from higher revenues, gains in Licensed software, Technology resale, Professional and Managed services units, and international revenue growth.

Cerner (CERN) Surpasses Q3 Earnings Estimates

by Zacks Equity Research

Cerner (CERN) delivered earnings and revenue surprises of 1.54% and -0.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Oct 24 Earnings Roster: BAX, CERN & More

by Zacks Equity Research

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Cerner's (CERN) AbleVets Buyout to Boost Federal Services

by Zacks Equity Research

Cerner (CERN) expects to close the AbleVets deal in the fourth quarter of 2019.

Cerner (CERN) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Top-line growth, expected increase in bookings and solid show by Population Health, Revenue Cycle and IT Works are anticipated to get reflected in Cerner's (CERN) Q3 earnings.

Cerner (CERN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SYNH vs. CERN: Which Stock Is the Better Value Option?

by Zacks Equity Research

SYNH vs. CERN: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Verizon Communications, PepsiCo, Biogen, Bank of New York ??? Mellon and Cerner

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Verizon Communications, PepsiCo, Biogen, Bank of New York ??? Mellon and Cerner

Mark Vickery headshot

Top Stock Reports for Verizon, PepsiCo & Biogen

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications (VZ), PepsiCo (PEP) and Biogen (BIIB).

Veeva Systems to Improve Patient Outcome With Crossix Buyout

by Zacks Equity Research

The latest acquisition fortifies Veeva Systems' (VEEV) foothold in the HCIT space further.